REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/20/2026
Back to search
Official data from USPTO
SPUTNIK V THE FIRST REGISTERED COVID-19 VACCINE PROVEN HUMAN ADENOVIRAL VECTOR TECHNOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/20/2026
Trademark type
Combined
Nice classes
5
Filing date
09/16/2020
Registration date
07/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/20/2021
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
RU
Examiner
SCHIMPF, TIMOTHY O
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "SPUTNIK V" above the stylized wording "THE FIRST REGISTERED COVID-19 VACCINE" above the stylized wording "PROVEN HUMAN ADENOVIRAL VECTOR TECHNOLOGY". The "P" in "SPUTNIK" is stylized with three short horizontal lines extending to the left.
Holders and representatives
Holders
Limited Liability Company "RDIF Asset management''
Representatives
Leo V. Gureff Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines against COVID-19
Publications
History of USPTO decisions and trademark events.
30 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/13/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/22/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
11/22/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/02/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/14/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2021
RFNT
REFUSAL PROCESSED BY IB
03/15/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/19/2021
RFRR
REFUSAL PROCESSED BY MPU
02/19/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/06/2021
CNRT
NON-FINAL ACTION WRITTEN
02/05/2021
DOCK
ASSIGNED TO EXAMINER
02/04/2021
DOCK
ASSIGNED TO EXAMINER
01/29/2021
MAFR
APPLICATION FILING RECEIPT MAILED
11/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/16/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/12/2020
Continuous trademark protection
Get notified about every new filing that threatens SPUTNIK V THE FIRST REGISTERED COVID-19 VACCINE PROVEN HUMAN ADENOVIRAL VECTOR TECHNOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.